Elkhawas Yasmin A, Gad Haidy A, AbdelRazek Mohamed M M, Mandour Asmaa A, Bishr Mokhtar M, Al Musayeib Nawal M, Ashour Mohamed L, Khalil Noha
Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Future University in Egypt, Cairo 11835, Egypt.
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
ACS Omega. 2024 Apr 26;9(18):20477-20487. doi: 10.1021/acsomega.4c01587. eCollection 2024 May 7.
The hydroethanol (70%) extracts of three species (, , and ) were analyzed using LC-ESI-MS/MS. Forty-five metabolites were identified, including different flavonoids, coumarin, polyacetylenes, and alkaloids, which were the most abundant class. By applying Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA) based on LC-ESI-MS/MS analysis, the three species were completely segregated from each other. In addition, the three extracts were tested for their antioxidant activities using a DPPH assay and as antidiabetic agents against α-glycosidase and α-amylase enzymes. extract demonstrated significant antioxidant activity with an IC50 value of 1.111 mg/mL, while showed mild suppressing activity on the α-glycosidase activity with an IC50 value of 270.8 μg/mL. A molecular simulation study was performed on the main compounds to predict their potential antidiabetic activity and pharmacokinetic properties. The molecular docking results confirmed the α-glycosidase inhibitory activity of the tested compounds, as seen in their binding mode to the key amino acid residues at the binding site compared to that of the standard drug acarbose. Furthermore, the predictive ADMET results revealed good pharmacokinetic properties of almost all of the tested compounds. The biological evaluation results demonstrated the promising activity of the tested compounds, aligned with the results.
使用LC-ESI-MS/MS分析了三种植物(、和)的氢乙醇(70%)提取物。共鉴定出45种代谢物,包括不同的黄酮类化合物、香豆素、聚乙炔和生物碱,其中生物碱类最为丰富。基于LC-ESI-MS/MS分析应用主成分分析(PCA)和层次聚类分析(HCA),这三种植物彼此完全分离。此外,使用DPPH测定法测试了这三种提取物的抗氧化活性,并测试了它们作为抗糖尿病药物对α-糖苷酶和α-淀粉酶的作用。提取物表现出显著的抗氧化活性,IC50值为1.111 mg/mL,而对α-糖苷酶活性表现出轻度抑制活性,IC50值为270.8 μg/mL。对主要化合物进行了分子模拟研究,以预测它们潜在的抗糖尿病活性和药代动力学性质。分子对接结果证实了测试化合物的α-糖苷酶抑制活性,从它们与结合位点关键氨基酸残基的结合模式与标准药物阿卡波糖的结合模式相比可以看出。此外,预测的ADMET结果显示几乎所有测试化合物都具有良好的药代动力学性质。生物学评估结果证明了测试化合物具有良好的活性,与结果一致。